Investor Relations

The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Press Releases

07-14-10
Aastrom Initiates IMPACT-DCM Extension Study for Control Patients

07-06-10
Aastrom to Pursue Phase 3 Clinical Program in CLI

more »

Events

06-11-10
Investor Conference Call and Webcast of the presentation of interim results from Aastrom's U.S. Phase 2b RESTORE-CLI clinical trial

06-11-10
Vascular Annual Meeting® of the Society for Vascular Surgery

more »